Literature DB >> 16557752

Dependence of time to death on molecular size of botulinum toxin.

C Lamanna1, L Spero, E J Schantz.   

Abstract

The molecular size of type A botulinum toxin affects the response in a time-to-death assay. Definitive statements of specific activity should be based on quantal assay.

Year:  1970        PMID： 16557752      PMCID： PMC415916          DOI： 10.1128/iai.1.4.423-424.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  4 in total

1.  Chromatographic isolation of hemagglutinin-free neurotoxin from crystalline toxin of Clostridium botulinum type A.

Authors:  B R DasGupta; D A Boroff
Journal:  Biochim Biophys Acta       Date:  1967-12-12

2.  Ultracentrifugal analysis of the crystalline toxin and isolated fractions of Clostridium botulinum type A.

Authors:  D A Boroff; R Townend; U Fleck; B R DasGupta
Journal:  J Biol Chem       Date:  1966-11-25       Impact factor: 5.157

3.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

4.  Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A.

Authors:  B R Dasgupta; D A Boroff; E Rothstein
Journal:  Biochem Biophys Res Commun       Date:  1966-03-22       Impact factor: 3.575
  4 in total
  10 in total

1.  Role of a protease in natural activation of Clostridium botulinum neurotoxin.

Authors:  B R Das Gupta; H Sugiyama
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

2.  Botulinal toxins and the problem of nomenclature of simple toxins.

Authors:  C Lamanna; G Sakaguchi
Journal:  Bacteriol Rev       Date:  1971-09

Review 3.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

Review 4.  Botulinum toxin injection of eye muscles to correct strabismus.

Authors:  A B Scott
Journal:  Trans Am Ophthalmol Soc       Date:  1981

5.  Activation of Clostridium botulinum type B toxin by an endogenous enzyme.

Authors:  B R DasGupta
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

6.  Regulation of neurotoxin and protease formation in Clostridium botulinum Okra B and Hall A by arginine.

Authors:  S I Patterson-Curtis; E A Johnson
Journal:  Appl Environ Microbiol       Date:  1989-06       Impact factor: 4.792

7.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

8.  Development of improved defined media for Clostridium botulinum serotypes A, B, and E.

Authors:  M E Whitmer; E A Johnson
Journal:  Appl Environ Microbiol       Date:  1988-03       Impact factor: 4.792

Review 9.  Critical Analysis of Neuronal Cell and the Mouse Bioassay for Detection of Botulinum Neurotoxins.

Authors:  Sabine Pellett; William H Tepp; Eric A Johnson
Journal:  Toxins (Basel)       Date:  2019-12-07       Impact factor: 4.546

10.  Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II.

Authors:  Ruth Kent; Adrian Robertson; Sandra Quiñones Aguilar; Charalampos Tzoulis; John Maltman
Journal:  Toxins (Basel)       Date:  2021-07-14       Impact factor: 4.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.